Could uric acid have a pathogenic role in pre-eclampsia?

Nature Reviews Nephrology

Volumn 6, Issue 12, 2010, Pages 744-748

  Martin, Annabel C ^a   Brown, Mark A ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

URIC ACID;

FEMALE; HUMAN; HYPERURICEMIA; METABOLISM; PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANCY; REVIEW; RISK FACTOR;

FEMALE; HUMANS; HYPERURICEMIA; PRE-ECLAMPSIA; PREGNANCY; RISK FACTORS; URIC ACID;

EID: 79955040230     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2010.125     Document Type: Article

References (45)

1. Paula, L. G. et al. Does uric acid provide information about maternal condition and fetal outcome in pregnant women with hypertension? Hypertens. Pregnancy 27, 413-420 (2008).
2. Sibai, B., Dekker, G. & Kupferminc, M. Preeclampsia. Lancet 365, 785-799 (2005).
3. Roberts, J. M. & Redman, C. W. Pre- eclampsia: more than pregnancy-induced hypertension. Lancet 341, 1447-1451 (1993).
4. Von Dadelzen, P, Magee, L. A. & Roberts, J. M. Subclassification of preeclampsia. Hypertens. Pregnancy 22, 143-148 (2003).
5. Maynard, S. E., Epstein, F. H. & Karumanchi, S. A. Preeclampsia and angiogenic imbalance. Annu. Rev. Med. 59, 61-78 (2008).
6. Maynard, S. E. et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. Clin. Invest. 111, 649-658 (2003).
7. Maynard, S. E. & Thadhani, R. Pregnancy and the kidney. J. Am. Soc. Nephrol. 20, 14-22 (2009).
8. LaMarca, B. D., Gilbert, J. & Granger, J. P. Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia. Hypertension 51, 982-988 (2008).
9. Karumanchi, S. A. & Bdolah, Y. Hypoxia and sFlt-1 in preeclampsia: the “chicken-and-egg" question. Endocrinology 145, 4835-4837 (2004).
10. Levine, R. J. et al. Circulating angiogenic factors and the risk of pre-eclampsia. N. Engl. J. Med. 350, 672-683 (2004).
11. Eremina, V. et al. VEGF inhibition and renal thrombotic microangiopathy. N. Engl. J. Med. 358, 1129-1136 (2008).
12. Conde-Agudelo, A., Villar, J. & Lindheimer, M. World Health Organization systemic review of screening tests for pre-eclampsia. Obstet. Gynaecol. 104, 1367-1391 (2004).
13. Carty, D. M., Delles, C. & Dominiczak, A. F. Novel biomarkers for predicting preeclampsia. Trends Cardiovasc. Med. 18, 186-194 (2008).
14. Cnossen, J. S. et al. Are tests for prediction pre-eclampsia good enough to make screening viable? A review of reviews and critical appraisal. Acta Obstet. Gynecol. Scand. 88, 758-765 (2009).
15. Sagen, N., Kjell, H. & Nilsen, S. Serum urate as a predictor of fetal outcome in severe preeclampsia. Acta Obstet. Gynecol. Scand. 63, 71-75 (1984).
16. Lim, K. H., Friedman, S. A., Ecker, J. L., Kao, L. & Kilpatrick, S. J. The clinical utility of serum uric acid measurements in hypertensive diseases of pregnancy. Am. J. Obstet. Gynecol. 178, 167-171 (1998).
17. Roberts, J. M. et al. Uric acid is as important as proteinuria in identifying fetal risk in women with gestational hypertension. Hypertension 46, 1263-1269 (2005).
18. Watanabe, S. et al. Uric acid, hominoid evolution, and the pathogenesis of salt- sensitivity. Hypertension 40, 355-360 (2002).
19. Griebsch, A. & Zollner, N. Effects of ribonucleotides given orally on uric acid production in man. Adv. Exp. Med. Biol. 4, 4 (1974).
20. Anzai, N., Kanai, Y & Endou, H. New insights into renal transport of urate. Curr. Opin. Rheumatol. 19, 151-157 (2007).
21. Irani, R. A. & Xia, Y. The functional role of the renin-angiotensin system in pregnancy and preeclampsia. Placenta 29, 763-771 (2008).
22. Gersch, C. et al. Reactions of peroxynitrite with uric acid: formation of reactive intermediates, altylated products and triuret, and in vivo production of triuret under conditions of oxidative stress. Nucleosides Nucleotides Nucleic Acids 28, 119-149 (2009).
23. Bainbridge, S. A. & Roberts, J. M. Uric acid as a pathogenic factor in preeclampsia. Placenta 29 (Suppl. A), S67-S72 (2008).
24. Kang, D. H. et al. Uric acid, endothelial dysfunction and pre-eclampsia: searching for a pathogenetic link. J. Hypertens. 22, 229-235 (2004).
25. Mazzali, M. et al. Elevated uric acid increases blood pressure in the rat by a novel crystal- independent mechanism. Hypertension 38, 1101-1106 (2001).
26. Fieg, D. I. et al. Hypothesis: uric acid, nephron number, and the pathogenesis of essential hypertension. Kidney Int. 66, 281-287 (2004).
27. Jossa, F. et al. Serum uric acid and hypertension: the Olivetti heart study. J. Hum. Hypertens. 8, 677-681 (1994).
28. Anker, S. D. et al. Uric acid and survival in chronic heart failure: Validation and application in metabolic, functional and haemodynamic staging. Circulation 107, 1991-1997 (2003).
29. Kannel, W. B. Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study. Am. Heart J. 114, 413-418 (1987).
30. Ohno, I. et al. Serum uric acid and renal prognosis in patients with IgA nephropathy. Nephron 87, 333-339 (2001).
31. Waring, W. S., Webb, D. J. & Maxwell, S. R. J. Effect of local hyperuricemia on endothelial dysfunction in the human forearm vascular bed. Br. J. Clin. Pharmacol. 49, 511 (2000).
32. Doehner, W. et al. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricaemic patients with chronic heart failure. Circulation 105, 2619-2624 (2002).
33. Khosla, U. M. et al. Hyperuricemia induces endothelial dysfunction. Kidney Int. 67, 1739-1742 (2005).
34. Granger, J. P et al. Pathophysiology of preeclampsia: linking placental ischaemia/hypoxia with microvascular dysfunction. Microcirculation 9, 147-160 (2002).
35. Mustard, J. F., Murphy, E. A., Ogryzlo, M. A. & Smythe, H. A. Blood coagulation and platelet economy in subjects with primary gout. Can. Med. Assoc. J. 89, 1207-1211 (1963).
36. Mene, P & Punzo, G. Uric acid: bystander or culprit in hypertension and progressive renal disease? J. Hypertens. 26, 2085-2092 (2008).
37. Johnson, R. J. et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41, 1183-1190 (2003).
38. Kang, D. H., Park, S. K., Lee, I. K. & Johnson, R. J. Uric acid-induced CRP expression: implication on cell proliferation and nitric oxide production of human vascular cells. J. Am. Soc. Nephrol. 16, 3553-3562 (2005).
39. Tsukimori, K., Yoshitomi, T., Morokuma, S., Fukushima, K. & Wake, N. Serum uric acid levels correlate with plasma hydrogen peroxide and protein carbonyl levels in preeclampsia. Am. J. Hypertens. 21, 1343-1346 (2008).
40. Gulmezoglu, A. M., Hofmeyr, G. J. & Oosthuisen, M. M. J. Antioxidants in the treatment of severe pre-eclampsia: an exploratory randomized controlled trial. Br. J. Obstet. Gynaecol. 104, 689-696 (1997).
41. Schackis, R. C. Hyperuricemia and preeclampsia: is there a pathogenic link? Med. Hypotheses 63, 239-244 (2004).
42. Lam, C., Lim, K. H., Kang, D. H. & Karumanchi, S. A. Uric acid and preeclampsia. Semin. Nephrol. 25, 56-60 (2005).
43. Homer, C. S. E. et al. Non-proteinuric pre- eclampsia: a novel risk indicator in women with gestational hypertension. J. Hypertens. 26, 295-302 (2008).
44. Koopmans, C. M. et al. Accuracy of serum uric acid as a predictive test for maternal complications in preeclampsia: Bi-variate meta-analysis and decision analysis. Eur. J. Obstet. Gynecol. Reprod. Biol. 146, 8-14 (2009).
45. Many, A., Hubel, C. A., Fisher, S. J., Roberts, J. M. & Zhou, Y. Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am. J. Pathol. 156, 321-331 (2000).